Over The Counter Drugs Market

North America Over-the-counter Drugs Market by Product Types (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Others), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Geography (The US, Mexico, and Canada) – Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021-2028

  • Report ID: HC-3414
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 41
  • No. Of Pages: 165
  • Format:
  • Pub. Date: Upcoming
  • Share:

The North America over-the-counter drugs (OTC) market size is anticipated to expand at a significant CAGR during the forecast period, 2021-2028. The growth of the market is attributed to increasing awareness related to general health concerns and advancements in healthcare and pharmaceutical industries.

North America Over The Counter Drugs Market Key Takeaway

OTC drugs, also known as non-prescription medicines, can be availed without a prescription. These drugs are safe and effective if they are administered according to the instructions as provided by a physician. Some examples of pain relief pills are Tylenol and Advil, whereas people regularly use dextromethorphan and antihistamines for cough. These drugs are usually available in local pharmacies, grocery shops, and even in gas stations. Dietary supplements contain dietary ingredients that are mainly used for provide nutrients to the body.

During the COVID-19 pandemic, the over-the-counter drugs market in North America was positively impacted, especially in 2020. Over six OTC drugs got approval from the Food and Drug Administration to treat diseases associated with mild symptoms.

Market Trends, Drivers, Restraints, and Opportunities

  • Improvement in lifestyles and age-related diseases is anticipated to drive the market growth during the forecast period.
  • Rising self directed consumer is estimated to spur the market growth in the coming years.
  • Growing convenience of direct purchase is projected to boost the market growth in the coming years.
  • Increasing affordability of OTC drugs is anticipated to drive the market growth during the forecast period.
  • Growing adoption and acceptance in developing markets, savings enabled by the usage of OTC drugs, and innovation and development in drugs are some of the major factors estimated to spur the market growth in the coming years.
  • Rising high market penetration is projected to boost the market growth in the coming years.
  • Wrong medication due to incorrect self diagnosis and misdiagnosis can restrict the market growth.
  • Lack of awareness regarding the active drugs in underdeveloped and rural regions is estimated to restrict the market growth.
  • Stringent regulatory policies by governing bodies and less awareness among individuals can restrict the market growth.
  • Drug abuse and the possibilities of drug addiction are the major challenges of the market.
  • Increasing number of pharmaceutical companies, retail outlets, hospitals pharmacies and online pharmacies in developed and developing countries can create lucrative opportunities in the market growth.

Scope of the Report

The report on the North America over the counter drugs market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

North America Over the Counter Drugs Market- Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Product Types (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Others), and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

Geography

The US, Mexico, and Canada

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Johnson and Johnson; Novartis AG; Bayer AG; Sanofi; and Pfizer Inc.

 

North America Over-the-counter (OTC) Drugs Market Segment Insights

Ophthalmic products segment to hold a significant market share

On the basis of product types, the market is divided into cough, cold, and flu products, analgesics, dermatology products, gastrointestinal products, vitamins, mineral, and supplements (VMS), weight-loss/dietary products, ophthalmic products, sleeping aids, and others. The weight-loss/dietary products segment is expected to hold a key share of the market in the coming years owing to rising awareness of the general population about health and the rise in the consumption of junk food, which is estimated to lead in the rising of lifestyle-related diseases However, the ophthalmic products segment is anticipated to expand at a rapid pace during the forecast period owing to increase in the bioavailability of the active substances and reduction in the susceptibility of drug forms to defense mechanism of the human eye.

North America Over The Counter Drugs Market Product Types


Online pharmacies segment is expected to grow at a rapid pace
Based on distribution channels, the market is segregated into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment is anticipated to hold a key share of the market in the coming years, as it ensure the safe and effective use of medicines. On the other hand, the online pharmacies segment is anticipated to expand at a rapid pace during the forecast period owing to better pricing than offline stores, with increased access, lower transaction, and product costs.

North America Over The Counter Drugs Market Distribution Channels

Mexico is estimated to account a major market share

In terms of regions, the market is classified as the US, Mexico, and Canada. The US is expected to constitute a key share of the market during the projected period due to increase in healthcare industries and rising investment of government to develop healthcare infrastructure. However, the market in Mexico is anticipated to expand at a rapid pace during the forecast period due to increase in awareness among the population about usage of OTC drugs to treat minor health issues.

Segments

Segments Covered in the Report
The North America over the counter drugs market has been segmented on the basis of

Product Types

  • Cough, Cold, and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Mineral, and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others
Distribution Channels
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
Geography
  • The US
  • Mexico
  • Canada
Key Players
  • Johnson and Johnson
  • Novartis AG
  • Bayer AG
  • Sanofi
  • Pfizer Inc.

Competitive Landscape

Key players competing in the over the counter drugs market includes Johnson and Johnson; Novartis AG; Bayer AG; Sanofi; and Pfizer Inc.

Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.

In 2018, Pfizer Inc. and GSK are working together for conducting extensive product line clinical trials under research and development stage.

North America Over The Counter Drugs Market Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Over-the-counter Drugs Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Over-the-counter Drugs Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Over-the-counter Drugs Market - Supply Chain
  4.5. Global Over-the-counter Drugs Market Forecast
     4.5.1. Over-the-counter Drugs Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Over-the-counter Drugs Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Over-the-counter Drugs Market Absolute $ Opportunity
5. Global Over-the-counter Drugs Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Over-the-counter Drugs Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Over-the-counter Drugs Demand Share Forecast, 2019-2026
6. North America Over-the-counter Drugs Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Over-the-counter Drugs Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Over-the-counter Drugs Demand Share Forecast, 2019-2026
7. Latin America Over-the-counter Drugs Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Over-the-counter Drugs Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Over-the-counter Drugs Demand Share Forecast, 2019-2026
8. Europe Over-the-counter Drugs Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Over-the-counter Drugs Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Over-the-counter Drugs Demand Share Forecast, 2019-2026
9. Asia Pacific Over-the-counter Drugs Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Over-the-counter Drugs Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Over-the-counter Drugs Demand Share Forecast, 2019-2026
10. Middle East & Africa Over-the-counter Drugs Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Over-the-counter Drugs Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Over-the-counter Drugs Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Over-the-counter Drugs Market: Market Share Analysis
  11.2. Over-the-counter Drugs Distributors and Customers
  11.3. Over-the-counter Drugs Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Johnson and Johnson
     11.4.2. Novartis AG
     11.4.3. Bayer AG
     11.4.4. Sanofi
     11.4.5. Pfizer Inc.

Segments Covered in the Report
The North America over the counter drugs market has been segmented on the basis of

Product Types

  • Cough, Cold, and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Mineral, and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others
Distribution Channels
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
Geography
  • The US
  • Mexico
  • Canada
Key Players
  • Johnson and Johnson
  • Novartis AG
  • Bayer AG
  • Sanofi
  • Pfizer Inc.

Key players competing in the over the counter drugs market includes Johnson and Johnson; Novartis AG; Bayer AG; Sanofi; and Pfizer Inc.

Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.

In 2018, Pfizer Inc. and GSK are working together for conducting extensive product line clinical trials under research and development stage.

North America Over The Counter Drugs Market Key Players

Buy Report